Since the Hsp90 client protein might degrade with the treatment of Hsp90 inhibitors, IHC detection of FASN in tumor xenograft samples was performed, and the results revealed that tumors treated with STA9090, or NB led to the reductions of FASN protein levels (Fig. 2L). Here, HSP90AA1 is linked to neoplasm.